Annual Conference, January 8, 2012, Sunday, 8.00 am - 7.00 pm
Westin San Francisco Airport, 1 Old Bayshore Hwy, Millbrae, CA 94030
The EPPIC annual life science conference combines networking, mentoring, keynote lectures and panel discussions on current topics. The annual conference also focuses on promoting cross border (US-India) collaborations and attracts multiple individuals and organizations interested in leveraging potential synergies. This year’s panels should give attendees a good grasp of the latest trends in industry: Personalized Medicine, Pre-clinical CROs, “Speed Pitch” presentations by Life Sciences start-ups, and Biobetters/Biosimilars. The annual conference will also feature a speed networking session to promote interaction among attendees. The conference brings budding and seasoned entrepreneurs, senior executives, scientists, venture capitalists and legal experts, together to tell their stories and will attract potential partners, employees and investors.
8.00 – 9.00 am REGISTRATION AND BREAKFAST
9.00 – 9.15 am WELCOME: RAMANI A. AIYER
EPPIC PRESIDENT, PRINCIPAL, SHASTA BIOVENTURES
9.15 – 10.00 am PLENARY SPEAKER:
“EMERGING TRENDS IN DRUG DISCOVERY; IMPLICATIONS FOR HEALTHCARE”
RICHARD EGLEN, VICE PRESIDENT & GENERAL MANAGER, CORNING LIFE SCIENCES
10.00 – 10.30 am KEYNOTE ADDRESS-1:
“THE STORY BEHIND THE LAUNCH OF ZELBORAF & ITS COMPANION DIAGNOSTIC”
WALTER H. KOCH, VICE PRESIDENT & HEAD OF GLOBAL RESEARCH, ROCHE MOLECULAR SYSTEMS
10.30 – 11.45 am PANEL1: PERSONALIZED DRUG DEVELOPMENT: MYTHS & REALITIES
Moderator: Shalabh Gupta, President & CEO, BioCycive, Inc.
Vern Norviel, Partner, Wilson Sonsini Goodrich & Rosati
Steve Dickman, Managing partner, CBT Advisors
Neil Gibson, CSO, Regulus Therapeutics
Christine A. Meda, President, Response Genetics
Calvin J. Kuo, Founder & Scientific Advisor, TOMA
11.45 – 12.30 pm SPEED NETWORKING
An opportunity to meet over 100 attendees with 3 minute quick introductions with a group of three attendees and also in a group setting. Please bring ~150 business cards.
12.30 – 1.30 pm LUNCH BREAK
1.30 – 2.00 pm KEYNOTE ADDRESS-2:
“A DECADE OF THE DRAGON AND THE TIGER DEALING WITH THE EAGLE”
JON NORTHRUP, CEO, BETA CAT PHARMACEUTICALSS
2.00 – 2.45 pm PANEL 2: IDEAS TO IND: GET GLOBAL
Moderator: Chitra Sharma, President, gCompliance
Jay De La Cruz, President and Founder, InTouch BioSolutions
Tony Zhang, CEO, Formurex
Philip Teitelbaum, Executive Director, Molecule Development Group, Covance
2.45 – 3.15 pm KEYNOTE ADDRESS-3:
“WHY EMERGING MARKETS ARE CRITICAL TO MEDICAL TECHNOLOGY INNOVATION”
GEETHA RAO, CEO, SPRINGBORNE LIFE SCIENCES &
VICE PRESIDENT, CORPORATE DEVELOPMENT, TRIPLE RING TECHNOLOGIES
3.15 – 3.30 pm COFFEE / NETWORKING BREAK
3.30 – 4.30 pm PANEL 3:
SPEED PITCH
Moderator: Mahendra Shah, Venture Partner, VIVO Ventures
Ajit Singh, Partner, Artiman Ventures
Anand Mehra, Partner, Sofinnova Ventures
Nandini Tandon, Managing Director, Lumira Capital
Rajeev Dadoo, Partner, SR One
4.30 – 5.00 pm KEYNOTE ADDRESS-4:
“BIOSIMILARS - AN OVERVIEW”
TIMOTHY L. MOORE, SENIOR VICE PRESIDENT, GENENTECH &
GLOBAL HEAD, PHARMACEUTICAL TECHNICAL OPERATIONS BIOLOGICS UNIT, ROCHE
5.00 – 6.00 pm PANEL 4:
THE BIOLOGICS (R)EVOLUTION: GENERICS, SIMILARS, BETTERS AND SUPERIORS
Moderator: Mohan Srinivasan, Director, Bristol-Myers Squibb/Medarex
Stephen Keane, President and CEO, Femta Biopharmaceuticals
Trevor Hallam, CSO, Sutro Biopharma
Pim Stemmer, CEO, Amunix
6.00– 6.15 pm CLOSING REMARKS: PRADEEP FERNANDES
CONFERENCE CO-CHAIR, FOUNDER & PRESIDENT, CELLWORKS GROUP
6.15 – 7.00 pm EVENING RECEPTION: COCKTAILS AND LIGHT REFRESHMENTS
To Volunteer or Sponsor, please contact:
Ramani A. Aiyer (ramani@shasta-bioventures.com), Pradeep Fernandes (pradeep@cellworksgroup.com), Jagath Reddy Junutula (jagathjr@gmail.com), or Executive Committee members. See web for details
CONFERENCE REGISTRATION - www.eppicglobal.org
